Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares OutstandingShares Outstanding
Ratios

Medifast (MED) Gross Profit (2016 - 2025)

Medifast's Gross Profit history spans 16 years, with the latest figure at $52.1 million for Q4 2025.

  • For Q4 2025, Gross Profit fell 40.9% year-over-year to $52.1 million; the TTM value through Dec 2025 reached $275.2 million, down 38.11%, while the annual FY2025 figure was $275.2 million, 38.11% down from the prior year.
  • Gross Profit reached $52.1 million in Q4 2025 per MED's latest filing, down from $62.2 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $321.7 million in Q2 2022 to a low of $52.1 million in Q4 2025.
  • Average Gross Profit over 5 years is $188.2 million, with a median of $194.0 million recorded in 2023.
  • Peak YoY movement for Gross Profit: soared 84.37% in 2021, then plummeted 48.34% in 2024.
  • A 5-year view of Gross Profit shows it stood at $278.3 million in 2021, then fell by 16.06% to $233.6 million in 2022, then plummeted by 39.48% to $141.4 million in 2023, then tumbled by 37.6% to $88.2 million in 2024, then crashed by 40.9% to $52.1 million in 2025.
  • Per Business Quant, the three most recent readings for MED's Gross Profit are $52.1 million (Q4 2025), $62.2 million (Q3 2025), and $76.6 million (Q2 2025).